What Mosie Baby does

Mosie Baby, operated by Mosie Inc. and headquartered in Austin, Texas, designs and sells the first FDA 510(k)-cleared over-the-counter intravaginal insemination kit for at-home fertility use. Founded in 2014 by Maureen and Marc Brown after a personal 2.5-year struggle with unexplained infertility, the company sells a single core product family — the Mosie Baby Kit ($129 for two attempts), a 2-Kit Bundle ($245), and a 3-Kit Fertility Plan ($360) — built around a patented slit-opening syringe designed to deliver laminar sperm flow and a purpose-built rounded semen collection cup. The device was cleared by the FDA in December 2023 as substantially equivalent to a predicate IUI device and is manufactured at an ISO 13485 US clean-room facility. Distribution is direct-to-consumer via mosiebaby.com (Shopify), Amazon Marketplace, Optum Store, and select physical retail, with shipments to the US, Canada, and the UK; subscription on 21- or 28-day cycles is available, and all products are FSA/HSA eligible. The company targets three primary segments — heterosexual couples with fertility challenges, LGBTQ+ couples, and single parents by choice — supported by an educational content engine (Conception 101 blog), a TikTok community (#mosiebaby), earned media in outlets such as Bloomberg, USA Today, and The New Yorker, and a medical provider referral network. Mosie was bootstrapped for most of its history, supplemented by a small 2022–2023 angel round totaling approximately $1.25M, and reached over 100,000 families helped and 120,000+ kits sold before being acquired by a larger brand-name company in fall 2025.

Name

Mosie Baby

Legal name

Mosie Inc.

Website

https://mosiebaby.com

Company type

Private

Founded year

2014

Operating status

Acquired

Headcount range

1–10 employees

Short description

Mosie Baby designs and sells the first FDA-cleared at-home intravaginal insemination kit, serving heterosexual couples with fertility challenges, LGBTQ+ couples, and single parents by choice through direct-to-consumer e-commerce and clinical provider referrals.

Ownership category

akta.pro rank

Product category

At-Home Fertility Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

akta.pro secondary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• At-home insemination kit
• Fertility products
• Intravaginal insemination
• Conception aids
• Home fertility device

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Technology or R&D, Personnel

Revenue model

1. Direct Product Sales: One-time purchase of Mosie Baby Kit and bundle options. Single kit includes 2 insemination attempts (2 syringes and 2 cups). Subscriptions available on 21 or 28-day cycles with automatic delivery.
2. Bundle Upsells: Multi-kit bundles offer increased attempts at discounted pricing. 2-kit bundle ($245) and 3-kit fertility plan ($360) maximize attempts and savings.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Mosie Baby designs, manufactures, and sells the first FDA-cleared at-home intravaginal insemination kit. The core product is a single-use, prescription-free medical device consisting of a patented syringe with a unique slit opening (for laminar sperm flow) paired with a custom semen collection cup. Kits are sold direct-to-consumer via e-commerce, Amazon, and Optum Store in single, 2-pack, and 3-pack bundle configurations.

Product overview

Mosie Baby is a unified product family built around its core FDA-cleared at-home insemination device. The portfolio consists of The Mosie Baby Kit for At-Home Insemination ($129 for 2 attempts), the 2-Kit At-Home Insemination Bundle ($245 for 4 attempts), and the 3-Kit Fertility Plan ($360 for 6 attempts). All kits contain the same patented Mosie insemination syringes with slit openings and Mosie semen collection cups. The company also offers educational content through its Conception 101 blog, a provider network, and customer support.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 100,000 families helped conceive since 2015
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core.

• Dr. John JaincoreOthers · 17 February 2026Board-certified Reproductive Endocrinologist with 30+ years of experience in fertility medicine and donor ethics. Appointed Medical Advisor February 2026.
• Premier Sperm BankcoreGTM or Marketing PartnerReferenced as recommended sperm donor partner on Mosie website. Links to premierSpermbank.com for users needing donor sperm. Provides integrated pathway for conception from donor selection through at-home insemination.
• Dr. Aimee EyvazzadehcoreOthersReproductive Endocrinologist and best-selling author. Endorses Mosie as 'the only home insemination kit I recommend to my patients.'
• Dr. Aaron SpitzcoreOthersUrologist and author of The Penis Book. Expert endorsement highlighting Mosie cup design superiority over urine sample cups for semen collection.
• Dr. Erin WolffcoreOthersFounder Pelex Health and Reproductive Physician Scientist. Provides clinical validation of FDA clearance process and product design.
• Dr. Lisa HansardcoreOthersFertility Specialist endorsing Mosie design and functionality. Quote: 'Mosie addresses an unmet clinical need I have witnessed as a fertility specialist.'
• Optum StorecoreChannel Partner/ Reseller/ DistributorFSA/HSA eligible retail distribution partner for Mosie Baby products.
• Medical Provider NetworkcoreChannel Partner/ Reseller/ DistributorNetwork of OBGYNs, urologists, reproductive endocrinologists, midwives, acupuncturists, fertility coaches, and doulas who recommend Mosie to patients. Includes provider directory on website.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• The Stork OTC (Rinovum Women's Health): Rinovum's Stork OTC is the most direct at-home conception device competitor to Mosie, offering a cervical cap insemination device sold OTC. Both target couples and individuals seeking clinical-grade home insemination without a fertility clinic visit, and compete on similar efficacy and ease-of-use claims.
• PherDal Fertility Science: PherDal makes a patented at-home intracervical insemination syringe kit, positioned as a clinical alternative for home use. Direct product overlap with Mosie's kit on single-use syringe-based home insemination for heterosexual, LGBTQ+, and single-parent-by-choice segments.
• Conceive Plus: Conceive Plus sells fertility-friendly personal lubricants and at-home conception support products used during the same trying-to-conceive journey Mosie targets. Direct overlap in retail channels (Amazon, pharmacy) and customer demographic.
• Fairhaven Health: Fairhaven Health manufactures fertility supplements, ovulation tests, and at-home conception aids sold to the same TTC demographic. Overlaps with Mosie on the consumer fertility journey, particularly ovulation timing and male fertility support.
• Natalist: Natalist is a reproductive wellness brand offering conception-support products, ovulation tests, and pregnancy tests with a strong DTC and clinical-channel presence. Direct peer in positioning, packaging, and target customer (millennial/Gen Z TTC consumers).
• Frida (Frida Fertility): Frida has expanded from baby care into the fertility and trying-to-conceive category, including ovulation tracking and conception support products. Direct peer in DTC channel, millennial parent branding, and product positioning around accessible at-home reproductive care.
• Proov: Proov sells FDA-cleared at-home progesterone tests and ovulation confirmation kits to the same TTC customer. Adjacent product category (at-home hormone-based fertility diagnostics) and shared retail and direct-to-consumer channels with Mosie.

Broad incumbents

• First Response (Church & Dwight): First Response is the dominant brand in pregnancy and ovulation testing, owned by Church & Dwight, and shares the same mass retail and pharmacy channels Mosie distributes through. Operates as a broad incumbent in adjacent fertility/TTC categories rather than competing directly in at-home insemination.
• Clearblue: Clearblue (Swiss Precision Diagnostics / Procter & Gamble) is a global incumbent in ovulation and pregnancy testing, serving the same TTC demographic as Mosie. Broad incumbent in the fertility testing category; serves as a complementary rather than directly competing brand.

Others

• Progyny: Progyny is a leading fertility benefits management company working with employers to provide clinical fertility coverage including IUI and IVF. Adjacent to Mosie in that Progyny members who exhaust clinical options represent an upstream (and downstream) customer pool, and Progyny's clinical positioning helps frame the at-home market Mosie serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• TikToktiktok.com/@mosiebaby
• Xx.com/mosiebaby
• Facebookfacebook.com/mosiebaby

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mosie Baby